Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ XETRA) stock market data APIs
€15.0642
0.25(1.7%)
as of December 12, 2025
Try our APIs with
free plan!
Eckert & Ziegler Strahlen- und Medizintechnik AG Financial Data Overview
Price chart is built with
Anychart
Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Prev. Close
15.0642
Open
15.3138
High
15.3934
Low
14.9125
52 wk Range
13.661-23.2499
Market Cap
942 M
P/E Ratio
23.1538
Shares Outstanding
62 574 K
Revenue
304 M
EPS
0.1348
Dividends (Yield)
0.0011
Beta
1.723
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eckert & Ziegler Strahlen- und Medizintechnik AG (top by weight)
Ticker
100-day Price Change
Weight
IS0S.F
iShares III Public Limited Company - iShares Emerging Asia Local Government Bond UCITS ETF
-1.98
(-2.61%)
0.00
IS0P.F
iShares V Public Limited Company - iShares Spain Government Bond UCITS ETF
-0.76
(-0.51%)
0.00
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eckert & Ziegler Strahlen- und Medizintechnik AG data using free add-ons & libraries
Get Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental Data
Eckert & Ziegler Strahlen- und Medizintechnik AG Fundamental data includes:
- Net Revenue: 304 M
- EBITDA: 81 991 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Eckert & Ziegler Strahlen- und Medizintechnik AG Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: NaN
Get Eckert & Ziegler Strahlen- und Medizintechnik AG End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eckert & Ziegler Strahlen- und Medizintechnik AG News
New
Eckert & Ziegler SE's (ETR:EUZ) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 4.5% over the past month, it is easy to disregard Eckert & Ziegler (ETR:EUZ). However, a closer look at its sound financials might cause you to think again. Given that fundamentals...
Undiscovered Gems in Europe to Explore This November 2025
As European markets face a pullback, with the pan-European STOXX Europe 600 Index ending 1.24% lower amid concerns about overvaluation in AI-related stocks, investors are increasingly looking towards ...
![[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](/build/assets/fallback4-BRnXXX09.jpg)
[Latest] Global Radiopharmaceutical CDMO Market Size/Share Worth USD 7.2 Billion by 2034 at a 9.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Radiopharmaceutical CDMO Market size & share ...
Exploring Three Undiscovered European Gems With Potential
As European markets navigate a complex landscape of interest rate policies and trade uncertainties, the pan-European STOXX Europe 600 Index remains steady, reflecting cautious investor sentiment. Amid...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
